Lower demand for semiconductor manufacturing equipment due to restrained domestic capital investment
First written in FY2017-Q1. 17 of 36 entries say "Mitigated", first in FY2017-Q3. Latest entry: FY2026.
The whole theme swung hardest in 2019: 13 of 26 companies on the "Worse" side.
13 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Revenue in the Mechatronics Systems Business increased from the previous consolidated fiscal year because semiconductor manufacturing systems rose on strong performance by bonders for optical communication modules for data centers, while medical equipment increased as overseas sales, including North America, rose after production increases began in the third quarter following resolution of the parts shortage.」
In contrast to the delayed recovery in demand for EVs and smartphones cited in the previous fiscal year, semiconductor manufacturing system sales increased in the current fiscal year as bonders for optical communications modules used in data centers performed well. - FY2026-H1Focus shifted to delayed demand recovery.Annual report
「Revenue from the Mechatronics Systems business declined year on year. Semiconductor manufacturing system sales fell because demand for EVs and smartphones was slow to recover, while medical equipment sales were affected by reduced production due to shortages of certain components.」
The factor behind the decline in semiconductor manufacturing system revenue has been described as delayed demand recovery, rather than the restraint of capital investment for EVs and smartphones cited in the previous fiscal year. - FY2025MaterialisedAnnual report
「Revenue from the Mechatronics Systems business increased from the previous consolidated fiscal year. Semiconductor manufacturing equipment sales declined as capital investment for EVs and smartphones was restrained, but medical equipment sales increased on strong overseas sales, including to North America and Europe.」
For semiconductor manufacturing equipment, restrained capital investment for EVs and smartphones has emerged as an actual factor behind the decline in sales. - FY2025-H1MitigatedAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Sales of semiconductor manufacturing systems rose as LED bonders and inspection equipment for Thailand increased, while medical equipment sales to overseas markets, including North America and Southeast Asia, remained strong and increased significantly. As a result, revenue was ¥20,310 million, up 24.0% year on year. In terms of earnings, operating profit increased to ¥1,510 million, up 40.7% year on year, as capacity utilisation improved with the increase in revenue.」
Rather than the previously cited decline in semiconductor manufacturing equipment demand due to the stagnation of the Chinese economy and other factors, the report cites higher sales of LED bonders and inspection equipment for Thailand. The Mechatronics Systems business achieved increases in both revenue and operating profit. - FY2024-Q3MaterialisedAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales declined slightly because the Chinese economy remained stagnant and demand had not yet reached a full-scale recovery. Cutting machine sales also declined due to weak domestic demand in the metalworking industry, but medical equipment sales to overseas markets, including Europe, North America and India, increased significantly.」
For semiconductor manufacturing equipment, the stagnation of the Chinese economy and the failure of demand to achieve a full-scale recovery have emerged as an actual slight decline in sales. Overall revenue from the Mechatronics Systems business increased due to higher overseas medical equipment sales. - FY2024-Q2MitigatedAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales were flat and cutting machine sales declined, but medical equipment sales to overseas markets, including Europe, North America and India, increased.」
Semiconductor manufacturing equipment sales were flat, and the previously cited period of declining demand was not mentioned for the quarter. Overall revenue from the Mechatronics Systems business increased due to higher overseas medical equipment sales. - FY2024-Q1MitigatedAnnual report
「Revenue from the Mechatronics Systems business increased year on year as sales of LED wire bonders for China increased and medical equipment sales to Europe remained strong. As a result, revenue was ¥7,369 million, up 10.5% year on year. In terms of earnings, operating profit declined 29.7% to ¥191 million because the sales mix shifted away from higher-value-added semiconductor manufacturing equipment.」
Semiconductor manufacturing equipment sales improved from the previous period of declining demand in China due to higher sales of LED wire bonders for China. Business profit, however, declined because the sales mix shifted away from higher-value-added models. - FY2023RestatedAnnual report
「Revenue from the Mechatronics Systems business declined from the previous fiscal year. Medical equipment sales increased as overseas sales to India, Europe and South Korea, which had fallen sharply due to COVID-19, recovered. Semiconductor manufacturing equipment sales, however, declined as the digital demand boom associated with the spread of remote work and other trends ran its course, while sales to China fell due to the economic slowdown caused by the country’s zero-COVID policy.」
For semiconductor manufacturing equipment, the end of the digital demand boom and the economic slowdown caused by China’s zero-COVID policy continue to be factors behind the full-year revenue decline. - FY2023-Q3MaterialisedAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales declined as the digital demand boom associated with the spread of remote work and other trends ran its course, while sales to China fell due to the economic slowdown caused by the country’s zero-COVID policy. Medical equipment sales increased as overseas sales to India, Europe and South Korea, which had fallen sharply due to COVID-19, recovered.」
For semiconductor manufacturing equipment, the end of the digital demand boom and the economic slowdown caused by China’s zero-COVID policy have emerged as actual factors behind the decline in sales to China. - FY2023-Q2RestatedAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Sales of semiconductor manufacturing equipment to China declined due to the economic slowdown caused by the country’s zero-COVID policy, but overseas medical equipment sales to India, Europe, South Korea and Taiwan, which had fallen sharply due to COVID-19, recovered.」
The economic slowdown caused by China’s zero-COVID policy continues to weigh on semiconductor manufacturing equipment sales to China. Overseas medical equipment sales, however, are recovering. - FY2023-Q1MaterialisedAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Sales of semiconductor manufacturing equipment to China declined significantly due to the economic slowdown caused by the country’s zero-COVID policy, but overseas medical equipment sales, including to India, Southeast Asia and Europe, recovered rapidly from the sharp decline caused by COVID-19 and increased significantly.」
The economic slowdown caused by China’s zero-COVID policy has emerged as an actual factor behind the significant decline in semiconductor manufacturing equipment sales to China. - FY2022MaterialisedAnnual report
「Revenue from the Mechatronics Systems business declined slightly. Semiconductor manufacturing equipment sales were affected by the economic slowdown caused by urban lockdowns in China and delays in procuring materials, including semiconductors and other components.」
Urban lockdowns in China and delays in procuring materials have emerged as actual factors behind the full-year decline in semiconductor manufacturing equipment sales. - FY2022-Q3MaterialisedAnnual report
「Revenue from the Mechatronics Systems business declined year on year. Cutting machines performed well, but both semiconductor manufacturing equipment and medical equipment were affected by delays in the procurement of materials, particularly semiconductors.」
In addition to the previously cited demand and shipment factors, including restrained domestic capital investment, US-China trade friction and COVID-19, delays in procuring materials, particularly semiconductors, have emerged as actual factors behind revenue declines in semiconductor manufacturing equipment and medical equipment. - FY2022-Q2MitigatedAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales increased against the backdrop of expanding capital investment demand in China aimed at improving semiconductor self-sufficiency, as in the previous fiscal year. Medical equipment sales also recovered slightly from the sharp decline in the previous fiscal year, despite continued weakness in demand for dialysis equipment due to the impact of COVID-19.」
Semiconductor manufacturing equipment sales increased against the backdrop of capital investment demand in China, while medical equipment sales recovered slightly from the previous fiscal year despite continued weak demand, indicating an improvement from the previous period of declining demand. - FY2022-Q1MitigatedAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales increased against the backdrop of expanding capital investment demand in China aimed at improving semiconductor self-sufficiency, as in the previous fiscal year. Medical equipment sales also recovered slightly from the sharp decline in the previous fiscal year, despite continued weakness in demand for dialysis equipment due to the impact of COVID-19. As a result, revenue was ¥5,162 million, up 7.0% year on year. In terms of earnings, operating profit was ¥287 million, compared with an operating loss of ¥270 million in the same period of the previous year, as the sales mix shifted toward higher-value-added semiconductor manufacturing equipment models.」
Semiconductor manufacturing equipment sales increased against the backdrop of capital investment demand in China, and the Mechatronics Systems business moved from an operating loss in the same period of the previous year to an operating profit. - FY2021MitigatedAnnual report
「Revenue from the Mechatronics Systems business increased from the previous fiscal year. Medical equipment sales declined as demand for dialysis equipment continued to fall, particularly in Europe and India, due to the spread of COVID-19. Semiconductor manufacturing equipment sales, however, increased significantly on expanding capital investment demand aimed at improving semiconductor self-sufficiency in China, as well as higher demand for information and electronic equipment resulting from lifestyle changes such as the increase in remote work during the pandemic.」
Semiconductor manufacturing equipment sales increased significantly against the backdrop of higher capital investment demand in China and increased demand for information and electronic equipment. Weaker demand due to restrained domestic capital investment has not been highlighted. - FY2021-Q3MitigatedAnnual report
「Semiconductor manufacturing equipment sales increased significantly as demand for capital investment expanded, particularly in China, driven by efforts to increase semiconductor self-sufficiency. Revenue therefore increased to ¥20,133 million, up 7.3% year on year. In terms of earnings, operating profit rose to ¥589 million, up 722.2% year on year, as the increase in semiconductor manufacturing equipment sales substantially improved capacity utilisation.」
Semiconductor manufacturing equipment sales increased against the backdrop of expanding capital investment demand in China. Revenue from the Mechatronics Systems business rose 7.3% and operating profit rose 722.2%. The risk of weaker demand due to restrained domestic capital investment has not been highlighted. - FY2021-Q2MitigatedAnnual report
「Revenue from the Mechatronics Systems business declined year on year. Semiconductor manufacturing equipment sales increased significantly as demand for capital investment expanded, particularly in China, driven by efforts to increase semiconductor self-sufficiency. However, medical equipment sales declined because demand for dialysis equipment continued to fall, particularly in Europe and India, due to the spread of COVID-19.」
Semiconductor manufacturing equipment has shifted from the previous period of declining demand to a significant increase driven by expanding capital investment demand against the backdrop of higher semiconductor self-sufficiency in China. Other demand-decline factors remain in the medical equipment business. - FY2021-Q1MitigatedAnnual report
「Revenue from the Mechatronics Systems business declined year on year. Semiconductor manufacturing equipment sales increased as market conditions in Japan and overseas moved toward recovery, particularly with higher sales to China, but medical equipment sales declined because demand for dialysis equipment continued to fall, especially under the impact of the spread of COVID-19.」
The report states that semiconductor manufacturing equipment has shifted from the previously cited demand decline, with market conditions in Japan and overseas moving toward recovery and sales to China increasing particularly strongly. - FY2020RestatedAnnual report
「Revenue from the Mechatronics Systems business declined. Semiconductor manufacturing equipment sales fell because, in addition to US-China trade friction, shipments overseas were postponed due to the impact of the spread of COVID-19.」
In addition to US-China trade friction, postponements of overseas shipments due to COVID-19 continued to be cited as factors behind the decline in semiconductor manufacturing equipment sales for the full fiscal year. - FY2020-Q3The influencing factor changed to the novel coronavirus disease (COVID-19).Annual report
「Revenue from the Mechatronics Systems business declined year on year. Sales of semiconductor manufacturing equipment fell because sales activities were restricted by the spread of COVID-19 and, from February onward, shipments of already-ordered equipment for overseas customers were suspended. Medical equipment sales also declined, particularly in Japan and China.」
The factors behind the decline in semiconductor manufacturing equipment have shifted from the previously cited US-China trade friction to restrictions on sales activities and the suspension of overseas shipments caused by the spread of COVID-19. - FY2020-Q2MaterialisedAnnual report
「Revenue from the Mechatronics Systems business declined year on year. Semiconductor manufacturing equipment sales fell due to the impact of US-China trade friction, while medical equipment sales to Japan and China also declined. As a result, revenue was ¥12,148 million, down 13.7% year on year, and the business posted an operating loss of ¥140 million, compared with operating profit of ¥729 million in the same period of the previous year.」
The decline in semiconductor manufacturing equipment caused by US-China trade friction became an actual factor behind the revenue decline, and the Mechatronics Systems business moved into an operating loss. - FY2019-Q3RestatedAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Sales of semiconductor manufacturing equipment to China declined due to the impact of US-China trade friction, but medical equipment sales increased on strong sales in Japan, China and Europe. As a result, revenue increased to ¥22,403 million, up 14.5% year on year. In terms of earnings, operating profit increased to ¥1,070 million, up 86.2% year on year, mainly because the sales mix shifted toward more profitable semiconductor manufacturing equipment models and medical equipment production remained high, reducing the fixed-cost burden.」
US-China trade friction continues to be cited as a factor behind the decline in semiconductor manufacturing equipment sales to China, while business profit has improved due to the higher sales mix of more profitable models, among other factors. - FY2019-Q2Continued impact of trade friction and profit improvement from higher-margin modelsAnnual report
「Revenue from the Mechatronics Systems business increased year on year. Sales of semiconductor manufacturing equipment to China declined due to the impact of US-China trade friction, but medical equipment sales increased on strong sales in Japan, China and Europe. As a result, consolidated revenue was ¥14,076 million, up 8.0% year on year. In terms of earnings, operating profit was ¥729 million, up 203.5% year on year, mainly because the sales mix shifted toward more profitable semiconductor manufacturing equipment models.」
US-China trade friction continues to be cited as a factor behind the decline in semiconductor manufacturing equipment sales to China, while operating profit has improved significantly as the sales mix shifted toward more profitable models. - FY2019-Q1The factor affecting performance changed to US-China trade frictionAnnual report
「Sales in the Mechatronics Systems business declined year on year. Although medical equipment sales to Japan, China and Europe were strong and increased, semiconductor manufacturing equipment sales to China declined because of the impact of US-China trade friction. As a result, consolidated net sales fell 3.7% to ¥5,933 million, and operating income fell 33.8% to ¥44 million.」
The factor behind the decline in semiconductor manufacturing equipment sales changed from the previous restraint in domestic capital investment to lower sales to China caused by the impact of US-China trade friction. The Mechatronics Systems business reported lower revenue and profit. - FY2018MitigatedAnnual report
「Sales in the Mechatronics Systems business increased from the previous consolidated fiscal year. Although cutting machine sales declined, medical equipment sales to India, China and Europe and semiconductor manufacturing equipment sales to China increased on strong demand.」
The company cites strong sales to China rather than a decline in semiconductor manufacturing equipment sales caused by restrained domestic capital investment. The Mechatronics Systems business reported higher revenue and profit for the full year. - FY2018-Q3MitigatedAnnual report
「Sales in the Mechatronics Systems business increased year on year. Although sales of cutting machines declined and medical equipment sales were flat, semiconductor manufacturing equipment sales increased on strong sales to China and South Korea.」
The company cites an increase driven by strong sales to China and South Korea, rather than a decline in semiconductor manufacturing equipment sales caused by restrained domestic capital investment. - FY2018-Q2MitigatedAnnual report
「Sales in the Mechatronics Systems business increased year on year. Although medical equipment sales declined slightly, cutting machine sales rose modestly and semiconductor manufacturing equipment sales increased substantially on strong sales to China and South Korea. As a result, consolidated net sales increased 12.7% to ¥13,029 million. On the earnings front, however, operating income declined 47.5% to ¥240 million because the company adopted strategic pricing, particularly for medical equipment, to expand sales in overseas markets, while costs rose to improve quality control.」
Rather than declining because of restrained domestic capital investment, semiconductor manufacturing equipment sales increased substantially on strong sales to China and South Korea. The Mechatronics Systems business as a whole reported higher revenue. - FY2018-Q1MitigatedAnnual report
「Sales in the Mechatronics Systems business increased substantially year on year. Medical equipment and cutting machines rose slightly, while semiconductor manufacturing equipment increased sharply on strong sales to China. As a result, consolidated net sales increased 42.4% to ¥6,161 million, and the business posted operating income of ¥67 million, compared with an operating loss of ¥108 million in the previous year.」
The business shifted from lower semiconductor manufacturing equipment sales caused by restrained domestic capital investment to higher revenue driven by strong sales to China, moving from an operating loss to operating income. - FY2017-Q3MitigatedAnnual report
「Sales in the Mechatronics Systems business increased year on year. Semiconductor manufacturing equipment sales rose slightly, while medical equipment sales to Europe and Southeast Asia were strong. As a result, consolidated net sales increased 13.0% to ¥18,857 million, and operating income increased substantially by 114.5% to ¥1,016 million as higher sales improved capacity utilization.」
Although semiconductor manufacturing equipment sales increased only slightly, they reversed the decline reported in the previous period, and the Mechatronics Systems business as a whole reported higher revenue and profit. - FY2017-Q2Shift from domestic factors to strong sales to ChinaAnnual report
「Sales in the Mechatronics Systems business increased year on year, as medical equipment sales to Europe and Southeast Asia and semiconductor manufacturing equipment sales to China were both strong. As a result, consolidated net sales increased 16.1% to ¥11,565 million, and operating income increased substantially by 638.9% to ¥457 million as higher sales improved capacity utilization.」
The decline attributed in the previous quarter to restrained domestic capital investment shifted in the current quarter to strong sales of semiconductor manufacturing equipment to China and medical equipment to Europe and Southeast Asia. - FY2017-Q1MaterialisedAnnual report
「Sales in the Mechatronics Systems business declined year on year. Medical equipment was broadly flat, and although sales of cutting machines for fine processing of thin materials increased, sales of semiconductor manufacturing equipment declined, mainly because of restrained domestic capital investment. As a result, consolidated net sales fell 6.7% year on year to ¥4,327 million, and the business posted an operating loss of ¥108 million, compared with an operating loss of ¥74 million in the previous year.」
Semiconductor manufacturing equipment declined because of restrained domestic capital investment, and the business posted an operating loss.